{"id":79,"date":"2020-08-02T23:28:31","date_gmt":"2020-08-03T06:28:31","guid":{"rendered":"https:\/\/blog.post-therapyreconditioning.com\/?page_id=79"},"modified":"2020-08-02T23:28:31","modified_gmt":"2020-08-03T06:28:31","slug":"is-money-spent-money-earned-in-healthcare","status":"publish","type":"page","link":"https:\/\/blog.post-therapyreconditioning.com\/index.php\/is-money-spent-money-earned-in-healthcare\/","title":{"rendered":"Is Money Spent, Money Earned in Healthcare?"},"content":{"rendered":"\n
\"\"<\/figure><\/div>\n\n\n\n
August 2, 2020<\/pre>\n\n\n\n
With the continued and active debates in healthcare concerning access, growing costs, Medicare for all, universal coverage, the United States population is still battling medical bankruptcy and out of control spending resulting from the complex pricing structure of the US healthcare system. The Patient Protection and Affordable Care Act, also known as the Affordable Care Act (ACA), did not specifically address pricing but did include some issues related to out-of-network cost-sharing for emergency service benefits. That was not enough. The purpose of this report is to shed some light on critical areas in spending and responsibility in which the US healthcare system must improve. The over-spend propagated by our current healthcare market system and the lack of responsibility of the US healthcare customers and consumers are the prime perpetrators in the ironical underachievement post-era ACA, possibly contributing to underperformance of increased access and cost-efficiency promised by this healthcare reform.<\/em><\/p>\n\n\n\n
Missed the Mark<\/h1>\n\n\n\n
Continued Over-Spending<\/h2>\n\n\n\n
Growing healthcare costs at nearly six percent annually are expected through 2024 and will account for just under 20% of our US GDP. Prescription drug increases 12% yearly and is a significant contributor. However, a downturn in consumer wealth has slowed the cost inflation, some say by 70%. Changes in healthcare financing, along with organizational change occurring with healthcare reform, had a greater impact on Medicare than social, economic status (SES) of different low income and uninsured groups. (Custer, 2016). Specifically, there are particularly high-cost consumers, less control of the producers of services, and not enough public education, contributing to more spending.<\/p>\n\n\n\n
High-Cost Users<\/h3>\n\n\n\n
Healthcare spending occurs disproportionately among a small portion of the population. Results of a cohort study of high-cost users (HCU) show that low-income significantly increased the odds of future HCU’s. However, HCU was not associated with food insecurity, personal income, and non-homeownership. Therefore, the authors concluded that interventions could be aimed to improve health and reduce costs by explicitly targeting the low-income population. (Fitzpatrick et al., 2015).
Value-based purchasing, incentivizing the delivery, and including clinical risk with payment reform are sensible. With the ACA, increased eligibility and scope of coverage was expected to increase the cost inflation of healthcare services but moderated by changes in plan design, integration, and delivery of care such as consolidating provider networks would attenuate the rise. However, Custer (2016) believed the increased price of healthcare would offset the declining rate, causing more healthcare spending, create complicated market structures, and consequently increase costs. This was correct.
The resultant is fewer buyers (insurers) facing fewer sellers (HCP) constraining the market, and Custer (2016) deems two predictive ways to resolve such market constraints. Brinkmanship-type aggressive negotiations that lead to either service prices or higher insurance premiums; or vertical integration that results in a trade-off between higher premiums and more efficient care. Increase price markets have led to more people utilizing fewer services per person at higher prices (Custer, 2016). Greater efficiency in healthcare delivery did not occur.<\/p>\n\n\n\n
Limited cost-control by consumers and customers.<\/h3>\n\n\n\n
Patient expectations and physician responses in controlling healthcare spending mitigating those requests are necessary. Physicians are cost consciousness and reported making trade-offs between financial and nonfinancial resources while attentive to their practice success. Their trade-offs require resourcefulness in the clinical workflow. Strategies may provide insight into policy measures and the physician role in healthcare resource use. (Sabbatini, et al., 2014).
Although physicians arbitrate medical resources, unfortunately, 30% of medical expenditures end up as waste. With pay-for-performance, shared risk, and other models, encouragement of cost-efficiency is present. However, Sabbatini et al. (2014) showed that patient expectation comes mostly from the internet and family-friend medical experience first and heavily influence the requests. What is seen as patients not having skin in the game, the patient considers the skin as already put in the game via the increase in premium and legislation. Physician considerations and the trade-offs reconciled end up with a more frequent clinical decision on the side of a patient concern than on limiting costs, or basically, they both spend anyway. Examples are seen in MRI, CT, and lab testing, such as TSH or blood work, when not indicated. The physician role becomes cover-themselves, and cost-conscious is averse to business and less than satisfactory to patients.<\/p>\n\n\n\n
Public education pitfall.<\/h3>\n\n\n\n
Accountable Care Organizations (ACO\u2019s), patient-centered medical homes, and other models can award financial incentives for cost management. Education to the public about overuse testing or treatment has helped spread the word of cost-containment. Now the issues appear to be the physician consideration may not be the same as public support of responsibility, as in the example of MRI ordered when not needed, but instead to cover the liability of the provider (Sabbatini et al., 2014).
Fitzpatrick et al. (2015) concluded that HCU\u2019s are often framed by cost-saving and access sustainability. The root of the problem stems from health disparities and social inequities. These factors are outside of the healthcare system. If the goal is to prevent those from becoming HCU, through education, the authors believe the answer lies in upstream population-based factors. They state a collaborative, intersectoral approach is needed, both inside and outside of the healthcare system, to align public and healthcare goals succinctly together. Although helpful with policy and interventions is difficult to achieve. Finally, educational interventions, especially for PCP, can make significant connections to patients, but more, the understanding of the concepts can help policymakers and those leaders in defining roles in the delivery of care. (Sabbatini, et al., 2014).<\/p>\n\n\n\n\n\n\n\n
Appropriate Placement of Financial Responsibility<\/h2>\n\n\n\n
If patients accepted more financial responsibility and possibly complained to a greater extent, more effort would be to reduce costs and not pay over-priced treatments or procedures. Focusing on the charge itself, market-based and consumer-driven transactions can only exist if patients know the costs of care. Typically, competition and comparison expectation to modulate price in a market, like other markets, would contribute to setting the price. However, when medical-only discussions, rather than financial, are present, it will not suffice. The burden placed on HCP’s for disclosure before treatment is unmanageable. Negotiations of rate by the payers typically, and not well known or publicized, pay lower than the uninsured, and the higher burden is placed on patients, at the full or chargemaster price. Lastly, for HCP\u2019s, knowing the negotiated rate again is beyond reasonable expectations (Hall, 2014).<\/p>\n\n\n\n
Informing and Disclosing.<\/h3>\n\n\n\n
Today, patients are the deciding factor on what care they accept to receive. Advising patients on costs has been historically away from patients until after treatment. It is now more in line with the current policy to include the price with the informed consent disclosure of out of pocket (OOP) before the patient receives care. Currently, the burden remains with the patient, the more valuable player. Too difficult to mandate and not appropriately placed with physician-patient encounters, the financial discussion of OOP must find a place because it cannot be separated from the medical discussion. Also, what is determined to be a benefit cannot be specified by the physician; this would not be objective. By informing patients of treatment options and financial risk, understanding the side effects, and the financial burden, a more shared decision gives more information to decide. A bill after the fact can have negative health impacts as well. (Hall, 2014).<\/p>\n\n\n\n
The morality of disclosure to assign accountability.<\/h3>\n\n\n\n
Our moral obligation to include disclosure of cost, the question of objections to care, where risk is strictly medical, not financial, moral obligation to disclose is even more important. The impetus is to focus on the economic and practical, not moral, even if it is the strongest argument. If universal state-funded healthcare did occur, we would be giving up the idea of morality to do what would be more advantageous, healthcare for all in our efficient and cost-effective US Healthcare system.
But in this case of our current situation, the sacrifice is preserving the expensive, complicated, and over-managed system which excludes people. Therefore, according to Hall (2014), our situation has both moral and financial working on the same vector. If the absurdity of not mandating disclosure with informed consent, which would not be informed, then how can reform be made on an unsubstantiated market that would do truly little to control rising costs? Desperately needed are specifics about actual costs and require changes to the payment system (Hall, 2014). Real cost transparency may do more to lower prices than healthcare reform, especially one that does not contain cost for healthcare services. Clear and straightforward pricing, perhaps moving away from Fee-for-Service (FFS) payment system to streamlined bundled or capitation to make disclosure easier.<\/p>\n\n\n\n
Expose the expensive system.<\/h3>\n\n\n\n
Cost-containment is not the reason for disclosure; however, it must be done and exemplifies most harm to the most vulnerable patients. Medical and financial factors end up being interconnected, where lack of disclosure is damaging to both health and finances. Disclosure should be simple and stand alone as the standard. In the US, confronting costs that come from disclosure is necessary and will expose the inequality in care. Put another way the moral justification does not disappear by moving questions about cost out of the clinic. By weighing the consequences, disclosing OOP may encourage providers to consider the new expensive treatment actual cost versus the significant improvements in more affordable and already available options. Although the belief is physicians would not be discussing but instead designate office personnel, if the discussion were commonplace, physicians would be able to anticipate problems (Hall, 2014). Providers could work out solutions, much like proprietors of business. In consumer-based care and a market-based healthcare system, some customers would not get particular care, due to not being in the market.<\/p>\n\n\n\n\n\n\n\n
Not a Comparative Outcome<\/strong><\/h2>\n\n\n\n
Five percent of healthcare consumers have accounted for 50% of the expense, while the bottom 50% user incurs less than five percent of the cost. How the link between SES and high cost is understood, and effects programs targeting HCU\u2019s is looked at by Fitzpatrick et al. (2015) to help bridge the knowledge gap.<\/p>\n\n\n\n
Financial Stress and Medical Bankruptcy<\/h2>\n\n\n\n
As noted in Fitzpatrick et al. (2015), results in support of SES as a multi-dimensional concept which operates at various levels and supports programs with interventions of social parameters. One parameter is immigrant and ethnic concentration areas, which are influenced by barriers and cultural beliefs to access and use healthcare. The disparity and access inequity contribute to who will be an HCU. This finding is also supported by the current research, such as low SES linked to preventable hospitalizations, higher rates, and more extended stays.
Financial constraints can lead a patient to refuse or delay needed treatment, or paying for the procedure can delay other bills. Healthcare debt as a reason for bankruptcy is increasing. These issues further support the patient autonomy of deciding and full ethical disclosure, regardless of payer. Unfortunately, uninsured persons receive the same high charge, but responsible for the full payment, not a reduced or negotiated rate, and according to the most recent Health & Human Service Office of the Assistant Secretary for Planning and Evaluation, another indication of the continued failure of ACA (HHS Secretary\u2019s Report, 2020).<\/p>\n\n\n\n\n\n\n\n
Impact<\/strong><\/h2>\n\n\n\n
One result of these missed opportunities in responsibility and pricing can be demonstrated in the issue of surprise billing. For emergency and scheduled inpatient care, a widespread and costly problem is when a patient receives an unexpected bill for medical services with no opportunity to make an informed consent of the provider, and no disclosure is given before the service. The HHS Secretary\u2019s report (2020) indicates a 41% incident rate of the last two years of a received surprise, and approximately half of them reported it was due to an out-of-network (OON) provider.
Patients must be able to make informed decisions, especially when vulnerable, related to such specialists as anesthesiologists or pathologists because they are not in the delivery of care model with ACA. Federal legislation is needed to protect all patients on a consistent and comprehensive basis, and outline how to make the charges public and accessible. (HHS Secretary\u2019s Report, 2020).<\/p>\n\n\n\n
Conclusion<\/h2>\n\n\n\n
Healthcare will evolve into three paths. Incentives tools to stay healthy for the patient, provider tools to keep patients healthy, and creating and sustaining integrated healthcare to maintain the health of the whole person (Custer, 2016). Money spent is money that is now lost. Because the healthcare facilities were private and the health insurance payers are increasingly public, amid the most expensive healthcare in the world (and best), increased spending is inevitable unless contained. Again, we are at the most expensive per capita and the highest percentage GDP spending apex. The findings outlined show why.<\/p>\n\n\n\n
References\nCuster, W. S. (2016). Health Care Cost Inflation in the Next Decade. Journal of Financial Service Professionals, 70(1), 37\u201339. https:\/\/search-ebscohost-com.proxy1.ncu.edu\/login.aspx?direct=true&db=bth&AN=111743162&site=eds-live\nFitzpatrick, T., Rosella, L. C., Calzavara, A., Petch, J., Pinto, A. D., Manson, H., . . . Wodchis, W. P. (2015). Looking Beyond Income and Education. American Journal of Preventive Medicine, 49(2), 161-171. doi:10.1016\/j.amepre.2015.02.018\nHall, A. (2014). Financial $ide Effects: Why Patients Should Be Informed of Costs. Hastings Center Report, 44(3), 41\u201347. https:\/\/doi-org.proxy1.ncu.edu\/10.1002\/hast.312\nHHS Secretary\u2019s Report on: Addressing Surprise Medical Billing (2020, July 29). Retrieved July 28, 2020, from 2020. https:\/\/HHS Secretary\u2019s Report.hhs.gov\/\nSabbatini, A.K., Tilburt, J.C., Campbell, E.G. et al. (2014). Controlling Health Costs: Physician Responses to Patient Expectations for Medical Care. J GEN INTERN MED 29, 1234\u20131241. https:\/\/doi-org.proxy1.ncu.edu\/10.1007\/s11606-014-2898-6<\/pre>\n\n\n\n
Strategies for Physicians<\/h4>\n\n\n\n
A. Educate Patients:  Range in depth, but when it comes to cost discussion does result in increased responsibility.\nB. Build trust:  Mostly will alleviate anxiety, and in that increased trust even more.\nC. Substitute:  When considering a less costly alternative, or deferral strategies, substitution can be successful.  <\/code><\/pre>\n","protected":false},"excerpt":{"rendered":"
August 2, 2020 With the continued and active debates in healthcare concerning access, growing costs, Medicare for all, universal coverage, the United States population is still battling medical bankruptcy and out of control spending resulting from the complex pricing structure of the US healthcare system. The Patient Protection and Affordable Care Act, also known as … <\/p>\n
Continue reading “Is Money Spent, Money Earned in Healthcare?”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/blog.post-therapyreconditioning.com\/index.php\/wp-json\/wp\/v2\/pages\/79"}],"collection":[{"href":"https:\/\/blog.post-therapyreconditioning.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/blog.post-therapyreconditioning.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/blog.post-therapyreconditioning.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.post-therapyreconditioning.com\/index.php\/wp-json\/wp\/v2\/comments?post=79"}],"version-history":[{"count":2,"href":"https:\/\/blog.post-therapyreconditioning.com\/index.php\/wp-json\/wp\/v2\/pages\/79\/revisions"}],"predecessor-version":[{"id":84,"href":"https:\/\/blog.post-therapyreconditioning.com\/index.php\/wp-json\/wp\/v2\/pages\/79\/revisions\/84"}],"wp:attachment":[{"href":"https:\/\/blog.post-therapyreconditioning.com\/index.php\/wp-json\/wp\/v2\/media?parent=79"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}